Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment
Future Medicinal Chemistry Editorial by Daniel Merk (Goethe University Frankfurt, Germany) discussing the potential of retinoid X receptor gamma-targeting agents to repair or reverse multiple sclerosis damage to the CNS through boosting remyelination.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet – the regenerative medicine network
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.